Roivant Sciences Ltd [NASDAQ: ROIV] plunged by -$0.22 during the normal trading session on while it closed the day at $10.38.
Roivant Sciences Ltd stock has also loss -3.17% of its value over the past 7 days. However, ROIV stock has declined by -17.16% in the 3 months of the year. Over the past six months meanwhile, it has lost -11.88% and lost -12.26% year-on date.
The market cap for ROIV stock reached $7.41 billion, with 719.63 million shares outstanding and 442.74 million shares in the current float. Compared to the average trading volume of 4.40M shares, ROIV reached a trading volume of 4396734 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Roivant Sciences Ltd [ROIV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ROIV shares is $16.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ROIV stock is a recommendation set at 1.22. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wolfe Research have made an estimate for Roivant Sciences Ltd shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 15, 2024. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on January 05, 2024, representing the official price target for Roivant Sciences Ltd stock. Previously, the target price had yet another raise to $14, while Deutsche Bank analysts kept a Buy rating on ROIV stock.
The Average True Range (ATR) for Roivant Sciences Ltd is set at 0.29, with the Price to Sales ratio for ROIV stock in the period of the last 12 months amounting to 75.92. The Price to Book ratio for the last quarter was 1.44, with the Price to Cash per share for the same quarter was set at 7.22.
ROIV stock trade performance evaluation
Roivant Sciences Ltd [ROIV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -3.17. With this latest performance, ROIV shares dropped by -6.91% in over the last four-week period, additionally sinking by -11.88% over the last 6 months – not to mention a drop of -11.28% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ROIV stock in for the last two-week period is set at 36.76, with the RSI for the last a single of trading hit 33.92, and the three-weeks RSI is set at 38.86 for Roivant Sciences Ltd [ROIV]. The present Moving Average for the last 50 days of trading for this stock 11.15, while it was recorded at 10.53 for the last single week of trading, and 11.35 for the last 200 days.
Roivant Sciences Ltd [ROIV]: An insightful look at the core fundamentals
Roivant Sciences Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 37.91 and a Current Ratio set at 37.91.
Roivant Sciences Ltd [ROIV]: Institutional Ownership
The top three institutional holders of ROIV stocks are: SB INVESTMENT ADVISERS (UK) LTD with ownership of 71.36 million shares, which is approximately 9.6983%. VIKING GLOBAL INVESTORS LP, holding 69.16 million shares of the stock with an approximate value of $$730.98 million in ROIV stocks shares; and VIKING GLOBAL INVESTORS LP, currently with $$705.23 million in ROIV stock with ownership which is approximately 9.0674%.
